https://www.selleckchem.com/pr....oducts/Cryptotanshin
Infections with Gram-positive bacteria, including acute bacterial skin and skin structure infections (ABSSSIs), are common in children. We describe a single-dose pharmacokinetics and safety study of tedizolid phosphate, a new oxazolidinone under investigation for the treatment of ABSSSIs in children, in hospitalized participants 2 to 12 years of age. This open-label, multicenter, phase 1 trial (NCT02750761) enrolled hospitalized children 2 to 12 years of age receiving treatment for a confirmed/suspected Gram-positive ba
Like
Comment
Share
